
zzso zzso is a novel zzso platinum zzso agent with a broad spectrum of zzso zzso zzso A phase I, zzso zzso study was performed to determine the maximum tolerated dose zzso of zzso zzso administered in combination with protracted zzso zzso zzso zzso zzso for up to six courses in patients with locally advanced and/or zzso zzso 

zzso escalation was based on observation of toxicity at each dose zzso zzso zzso zzso zzso escalated to zzso zzso was studied in combination with zzso zzso zzso zzso per zzso 

zzso into the study were 14 zzso The most frequent zzso were zzso zzso fatigue and zzso The zzso zzso was not determined as zzso patients experienced grade 3 or 4 zzso that interrupted the planned administration of zzso zzso on day 15 (of zzso Although these events were not zzso as defined in the zzso they imposed limitations on the dose of zzso zzso zzso zzso activity was zzso a partial response in one patient zzso with invasive breast zzso zzso disease was confirmed in three patients zzso These four patients all completed the planned six courses of combined zzso 

In light of the lack of septic events associated with the recorded zzso it may be possible to safely continue zzso zzso despite the grade 3 or 4 zzso or modify the zzso schedule and administer therapy on days zzso of the zzso cycle, but these modifications were not considered in this zzso 

